![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, September 04, 2010 10:04:47 PM
you are more interested in arguing.
yes, I talked to the company, no, not the FDA, but I read what I needed on the FDA suite
ever done a metrics sheet? I don't know what the market share or the pricing will be, that's why you do a broad projection. I am trying to get real data, and have some
fyi, 15% at $40 puts stock at $1.8 with no multiple.
38M Plavix users US
i've read all of your posts, and found some helpful, but mostly emotion and doubt.
VRML, ANZ, all had naysayers...
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM